头孢噻肟
脑膜炎奈瑟菌
微生物学
美罗培南
环丙沙星
氨苄西林
青霉素
医学
奈瑟菌
头孢曲松
利福平
阿奇霉素
抗生素
甲氧苄啶
磺胺甲恶唑
抗生素耐药性
生物
细菌
遗传学
作者
Lina Xu,Fenglin Han,Dan Wu,Bing Zhu,Wei Gao,Yifan Gao,Y X Li,Zhongjun Shao
出处
期刊:PubMed
日期:2021-02-06
卷期号:55 (2): 207-211
被引量:3
标识
DOI:10.3760/cma.j.cn112150-20200922-01227
摘要
Objective: To analyze the antimicrobial resistance characteristics of 538 Neisseria meningitidis isolated from 2005 to 2019 in China. Method: Total of 538 Neisseria meningitidis strains collected from 30 provinces in China from 2005 to 2019. Antimicrobial susceptibility test were performed based on the standards of clinical and laboratory standardization association (CLSI) including 11 recommended antibiotics. Gradient diffusion method was used to detect the antibiotic sensitivity of Neisseria meningitidis. Results: All 538 strains were sensitive to azithromycin, meropenem, chloramphenicol, rifampicin and ceftriaxone. As to other six antibiotics, the antibiotics sensitivity rates were cefotaxime (97.4%, 524 strains), ampicillin (87.7%, 472 strains), penicillin (84.8%, 456 strains), minocycline (95.2%, 512 strains), ciprofloxacin (24.9%, 134 strains) and trimethoprim/sulfamethoxazole (11.2%, 60 strains) respectively. Conclusions: Neisseria meningitidis isolated from 2005-2019 in China were all sensitive to azithromycin, meropenem, chloramphenicol, rifampicin and ceftriaxone. It should highlight Neisseria meningitidis resistant to cefotaxime, ampicillin and penicillin. Ciprofloxacin and sulfamethoxazole are not recommended as the priority choice for clinical treatment and prophylactic medication.
科研通智能强力驱动
Strongly Powered by AbleSci AI